A detailed history of Td Asset Management Inc transactions in Zai Lab LTD stock. As of the latest transaction made, Td Asset Management Inc holds 224,728 shares of ZLAB stock, worth $6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
224,728
Previous 221,970 1.24%
Holding current value
$6 Million
Previous $3.85 Million 41.03%
% of portfolio
0.01%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$16.25 - $24.14 $44,817 - $66,578
2,758 Added 1.24%
224,728 $5.42 Million
Q2 2024

Aug 02, 2024

BUY
$13.72 - $21.55 $41,160 - $64,650
3,000 Added 1.37%
221,970 $3.85 Million
Q1 2024

May 08, 2024

SELL
$15.95 - $26.8 $264,770 - $444,880
-16,600 Reduced 7.05%
218,970 $3.51 Million
Q4 2023

Feb 12, 2024

BUY
$22.97 - $30.58 $427,242 - $568,788
18,600 Added 8.57%
235,570 $6.44 Million
Q3 2023

Oct 27, 2023

BUY
$22.72 - $31.49 $2.63 Million - $3.65 Million
115,885 Added 114.64%
216,970 $5.27 Million
Q2 2023

Aug 09, 2023

BUY
$25.3 - $39.67 $326,370 - $511,743
12,900 Added 14.63%
101,085 $2.8 Million
Q1 2023

May 10, 2023

BUY
$30.21 - $48.1 $1.4 Million - $2.24 Million
46,500 Added 111.55%
88,185 $2.93 Million
Q3 2022

Nov 07, 2022

BUY
$34.2 - $51.69 $112,860 - $170,577
3,300 Added 8.6%
41,685 $1.46 Million
Q2 2022

Aug 04, 2022

SELL
$23.14 - $49.68 $101,839 - $218,641
-4,401 Reduced 10.29%
38,385 $1.33 Million
Q4 2021

Feb 10, 2022

BUY
$54.9 - $105.21 $285,480 - $547,092
5,200 Added 13.83%
42,786 $2.69 Million
Q3 2021

Nov 09, 2021

BUY
$105.0 - $178.37 $294,000 - $499,436
2,800 Added 8.05%
37,586 $3.96 Million
Q2 2021

Aug 11, 2021

BUY
$125.11 - $180.0 $842,991 - $1.21 Million
6,738 Added 24.02%
34,786 $5.03 Million
Q1 2021

May 14, 2021

BUY
$126.27 - $191.71 $781,485 - $1.19 Million
6,189 Added 28.31%
28,048 $3.74 Million
Q4 2020

Feb 16, 2021

BUY
$81.94 - $135.34 $594,065 - $981,215
7,250 Added 49.63%
21,859 $2.96 Million
Q3 2020

Nov 10, 2020

BUY
$73.3 - $89.48 $425,140 - $518,984
5,800 Added 65.84%
14,609 $1.22 Million
Q2 2020

Aug 13, 2020

BUY
$48.82 - $82.53 $34,174 - $57,771
700 Added 8.63%
8,809 $723,000
Q1 2020

May 15, 2020

SELL
$39.1 - $62.9 $86,098 - $138,505
-2,202 Reduced 21.36%
8,109 $417,000
Q3 2019

Nov 07, 2019

SELL
$30.47 - $37.65 $15,235 - $18,825
-500 Reduced 4.62%
10,311 $334,000
Q1 2019

May 08, 2019

SELL
$21.71 - $31.54 $229,170 - $332,936
-10,556 Reduced 49.4%
10,811 $319,000
Q3 2018

Nov 01, 2018

BUY
$17.8 - $25.35 $75,952 - $108,168
4,267 Added 24.95%
21,367 $416,000
Q2 2018

Jul 31, 2018

BUY
$18.0 - $25.01 $3,600 - $5,002
200 Added 1.18%
17,100 $398,000
Q1 2018

May 11, 2018

BUY
$20.05 - $26.96 $118,295 - $159,064
5,900 Added 53.64%
16,900 $361,000
Q4 2017

Feb 02, 2018

BUY
$21.23 - $34.09 $233,530 - $374,990
11,000
11,000 $234,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.62B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.